Evoke Pharma
EVOK
#10180
Rank
HK$0.14 B
Marketcap
HK$85.09
Share price
-0.09%
Change (1 day)
164.11%
Change (1 year)

Revenue for Evoke Pharma (EVOK)

Revenue in 2025 (TTM): HK$99.73 Million

According to Evoke Pharma 's latest financial reports the company's current revenue (TTM ) is HK$99.6 Million. In 2024 the company made a revenue of HK$79.57 Million an increase over the revenue in the year 2023 that were of HK$40.46 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Evoke Pharma from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$99.73 M25.34%
2024 HK$79.57 M96.66%
2023 HK$40.46 M106.43%
2022 HK$19.6 M55.35%
2021 HK$12.61 M6970.15%
2020 HK$0.17 M
2019 N/A
2018 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Ironwood Pharmaceuticals
IRWD
HK$2.63 B 2,549.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
HK$6.43 B 6,362.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amphastar Pharmaceuticals
AMPH
HK$5.63 B 5,553.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
HK$1.66 B 1,572.09%๐Ÿ‡บ๐Ÿ‡ธ USA